Abstract

Objectives: This study aims to investigate the possible influence of the model, cationic, surface-active solute chlorpromazine hydrochloride (CPZ-HCl) on the size of small unilamellar dimyristoyl phosphatidylcholine (DMPC) liposomes as a function of temperature and CPZ-HCl concentration, below and above the critical micelle concentration (CMC).
 Methods: Small unilamellar DMPC liposomes were prepared by dissolving DMPC in chloroform and the solvent was rota-evaporated in a water bath adjusted at 40 °C. The lipid film was then dispersed in 0.1 M KCl solution adjusted at pH 6.2 to form large multilamellar liposomes which are then sonicated and fractionated via Sepharose 2B-Cl gel. The elution profile was followed spectrophotometrically at λ 260 nm. Combined fractions from the trailing edge of the included peak which is due to small unilamellar liposomes, were used as a source throughout this study. The SOFICA light scattering photometer (Model 42000) was used to determine the weight average liposomes weight (Lw) of small unilamellar DMPC liposomes. The Lw was determined in the absence and presence of CPZ-HCl both above and below the CMC over the temperature range of 25 °C to 40 °C.
 Results: The Lw was observed to increase linearly in the absence and presence of CPZ-HCl.
 The Lw was observed to increase linearly in the absence of CPZ-HCl, from 1.88×106+0.02 g/mol at 25 °C to 3.25×106+0.03 g/mol at 40 °C. Similarly, the Lw was observed to increase linearly in the present of CPZ-HCl, for example at 18 mmol drug concentration, the Lw increases from 11×106+0.04 g/mol at 25 °C to 13.75×106+0.03 g/mol at 40 °C. When the data are presented as a function of CPZ-HCl concentration, a gradual increase in Lw was observed below the CMC. Little increase in Lw however, was observed at post-micellar concentrations of 14 mmol and 18 mmol.

Highlights

  • Liposomes have been extensively used as drug delivery systems for a wide range of drugs [1,2,3,4,5,6,7,8,9,10]

  • The increase in liposomes weight (Lw) in the presence of the model cationic, surface-active solute CPZ-HCl as a function of concentration and temperature indicate that CPZ-HCl interacts with small unilamellar dimyristoyl phosphatidylcholine (DMPC) liposomes at concentrations below and above the critical micelle concentration (CMC)

  • The present study investigates the possible influence of the model, cationic, surface active solute CPZ-HCl on the size of small unilamellar DMPC liposomes as a function of temperature and chlorpromazine hydrochloride (CPZHCl) concentration

Read more

Summary

Introduction

Liposomes have been extensively used as drug delivery systems for a wide range of drugs [1,2,3,4,5,6,7,8,9,10]. Liposomes were the first nanoscale drug delivery systems to be approved for clinical use in 1995. An equilibrium dialysis study with CPZHCl showed that the drug has a similar binding affinity for liver microsomes, mitochondrial membrane, myelin vesicles, erythrocyte membranes as well as sonicated egg lecithin liposomes and it was concluded that the major intracellular binders for CPZ-HCl are the non-polar moieties of membrane phospholipids and hydrophobic interactions are mainly involved [24]. The effect of CPZ-HCl on the rat synaptic plasma membranes using nitroxide spin labels revealed that the drug decreases the mobility of the polar head group and it was observed that such action was inhibited by Ca ions [25]. A study using P-NMR has indicated that CPZ-HCl binding to phosphatidylserine in the bilayer enhances phospholipid head group mobility [25]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call